The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806. (Q40210597)
Jump to navigation
Jump to search
scientific article published on 8 November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806. |
scientific article published on 8 November 2006 |
Statements
1 reference
The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806. (English)
1 reference
Hui K Gan
1 reference
Francesca Walker
1 reference
Antony W Burgess
1 reference
Angela Rigopoulos
1 reference
Andrew M Scott
1 reference
8 November 2006
1 reference
1 reference
Identifiers
1 reference